Anthonie C. Vanekris, Director at Gabelli Healthcare & WellnessRx Trust (GRX), sold 9,000 shares at $9.26 ($83K) on 2025-10-08, disclosed to the SEC on 2025-12-02.
Open-market sale of $83k GRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.12 | 2,000 | $18K | 22.0% |
| 2 | $9.20 | 2,000 | $18K | 22.2% |
| 3 | $9.50 | 200 | $2K | 2.3% |
| 4 | $9.50 | 800 | $8K | 9.2% |
| 5 | $9.26 | 1,000 | $9K | 11.2% |
| 6 | $9.27 | 1,000 |
| $9K |
| 11.2% |
| 7 | $9.15 | 1,000 | $9K | 11.0% |
| 8 | $9.12 | 1,000 | $9K | 11.0% |
| Total | $9.22 avg | 9,000 | $83K | 100% |
| Filing → |
| BCV | SELL | 2026-06-02 | $27K | — | Filing → |
| GGN | SELL | 2026-06-01 | $13K | — | Filing → |
| GDV | SELL | 2025-12-02 | $25K | — | Filing → |